Cimpress (NASDAQ: CMPR) approves new $200M open-ended share repurchase

Rhea-AI Filing Summary

Cimpress plc announced that its Board of Directors has authorized a new share repurchase program for up to $200,000,000 aggregate purchase price of its issued and outstanding ordinary shares. The authorization has no expiration date and allows repurchases on the open market, through privately negotiated transactions, or via one or more self-tender offers.

This new authorization replaces the remaining unused portion of the prior repurchase authorization approved on May 29, 2024, which was terminated immediately before the new program took effect. The Board emphasized that Cimpress is not required to use the full authorized amount and that repurchases are subject to its net leverage and near-term capital allocation commentary from its January 29, 2026 earnings document and may be suspended or discontinued at any time.

Insights

Equity Capital Markets Analyst

Cimpress sets up a new $200M, open-ended buyback but actual repurchases remain discretionary and constrained by leverage and capital plans.

Cimpress has authorized repurchases of up to $200,000,000 of ordinary shares with no expiration date. The program permits buybacks through open-market purchases, privately negotiated deals, or self-tender offers, giving the company multiple mechanisms to reduce its share count when it chooses.

This authorization replaces the unused portion of the prior program from May 29, 2024, which was terminated as the new one became effective. The company states that it may not use the full amount and that activity remains subject to net leverage and near-term capital allocation commentary from its January 29, 2026 earnings document, meaning execution depends on balance sheet and capital-use priorities.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

New buyback authorization: $200,000,000 aggregate purchase price Prior authorization date: May 29, 2024 Earnings reference date: January 29, 2026

3 metrics

New buyback authorization $200,000,000 aggregate purchase price Authorized by Board on March 25, 2026

Prior authorization date May 29, 2024 Earlier repurchase authorization terminated upon effectiveness of new one

Earnings reference date January 29, 2026 Net leverage and capital allocation commentary guiding repurchases

Key Terms

share repurchase authorization, self-tender offers, net leverage, ordinary shares, +1 more

5 terms

share repurchase authorization financial

"the Board of Directors of Cimpress plc authorized the repurchase, from time to time"

A share repurchase authorization is a company's official approval to buy back its own shares from the market. This signals that the company believes its stock is a good investment and can help increase the value of remaining shares by reducing how many are available. For investors, it often suggests confidence from the company and can influence the stock’s price.

self-tender offers financial

"on the open market, through privately negotiated transactions, or in one or more self-tender offers"

net leverage financial

"Share repurchases remain subject to the net leverage and near-term capital allocation commentary"

Net leverage measures how many years it would take for a company to pay off its outstanding debt using its annual operating cash flow, after subtracting cash on hand from total debt. Think of it like a household’s mortgage balance minus savings divided by yearly income; a lower number means the company is in a safer position to handle debt, while a higher number signals greater financial risk and potential pressure on profits or growth.

ordinary shares financial

"aggregate purchase price ... of Cimpress' issued and outstanding ordinary shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Form 8-K regulatory

"Form 8-K"

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

Understanding 8-K Material Events →

0001262976false00012629762022-11-162022-11-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________________________

Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):			March 25, 2026

__________________________________________

Cimpress plc

(Exact Name of Registrant as Specified in Its Charter)

__________________________________________

Ireland

000-51539

98-0417483

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

First Floor Building 3,			Finnabair Business and Technology Park
A91 XR61
Dundalk, Co. Louth
Ireland
(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: +353 42 938 8500

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

__________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company, as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐    

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Exchange on Which Registered

Ordinary Shares, nominal value per share of €0.01

CMPR

NASDAQ

Global Select Market

Item 8.01.  Other Events

On March 25, 2026, the Board of Directors of Cimpress plc authorized the repurchase, from time to time, with no expiration date, of up to $200,000,000 aggregate purchase price (excluding any fees, commissions, or other expenses of such purchases) of Cimpress' issued and outstanding ordinary shares on the open market, through privately negotiated transactions, or in one or more self-tender offers. This authorization replaces the remaining unused portion of the share repurchase authorization previously approved by the Board of Directors on May 29, 2024, which was terminated immediately prior to the effectiveness of the new authorization.

The Board’s authorization does not necessarily mean that Cimpress will repurchase the full dollar amount authorized. Share repurchases remain subject to the net leverage and near-term capital allocation commentary disclosed in Cimpress’ most recent earnings document published on January 29, 2026 and may be suspended or discontinued at any time.

Item 9.01.    Financial Statements and Exhibits

(d)    Exhibits

Exhibit
No.						Description
104						Cover Page Interactive Data File, formatted in iXBRL

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

March 31, 2026 Cimpress plc          

			By:			/s/ Sean E. Quinn
						Sean E. Quinn
						Executive Vice President and Chief Financial Officer

FAQ

What did Cimpress (CMPR) announce in its latest Form 8-K?

Cimpress announced a new Board-authorized share repurchase program for up to $200,000,000 of its ordinary shares. The authorization has no expiration date and allows purchases via open-market transactions, privately negotiated deals, or one or more self-tender offers, at the company’s discretion.

How large is Cimpress’ new share repurchase authorization?

The new Cimpress authorization covers up to $200,000,000 in aggregate purchase price of issued and outstanding ordinary shares. This amount excludes any related fees, commissions, or other expenses and represents the maximum dollar value the company may deploy under this specific program.

Does the Cimpress (CMPR) share repurchase authorization have an expiration date?

The Cimpress share repurchase authorization has no expiration date, allowing buybacks to occur from time to time. However, the Board notes repurchases may be suspended or discontinued at any time and are not guaranteed to reach the full authorized dollar amount.

What happened to Cimpress’ previous share repurchase program?

The new authorization replaces the remaining unused portion of the prior repurchase program approved on May 29, 2024. That earlier authorization was terminated immediately before the effectiveness of the new $200,000,000 program, consolidating buyback capacity under the updated authorization.

What conditions affect Cimpress’ decision to repurchase shares under this authorization?

Cimpress states that repurchases remain subject to its net leverage and near-term capital allocation commentary from the earnings document published on January 29, 2026. The company also notes it may suspend, discontinue, or choose not to use the full authorized amount.

How can Cimpress execute share repurchases under the new program?

Cimpress may repurchase shares on the open market, through privately negotiated transactions, or in one or more self-tender offers. This mix of methods provides flexibility in how the company conducts buybacks within the overall $200,000,000 authorization limit.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 22.2 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.7 KB